US Patent 11285138 Method of treating C3 glomerulopathy
Patent 11285138 was granted and assigned to ChemoCentryx on March, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Petrus Bekker0
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112851380
Date of Patent
March 29, 2022
0Patent Application Number
161845350
Date Filed
November 8, 2018
0Official Website
Patent Citations
Patent Primary Examiner
CPC Code
Edits on 31 Mar, 2023
Golden AI
Infobox
Edits on 6 Oct, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Mar, 2022
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+171 characters)
US Patent 11285138 Method of treating C3 glomerulopathy
Article
Methods of treating a human suffering from or susceptible to C3 glomerulopathy comprising administering to the human an effective amount of a C5aR antagonist are provided.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11285138
Date of patent
March 29, 2022
Patent application number
16184535
Date Filed
November 8, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 11285138 Method of treating C3 glomerulopathy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
